Germinal centers (GCs) are specialized microenvironments in secondary lymphoid organs where high-affinity antibody-producing B cells are selected based on B-cell antigen receptor (BCR) signal strength. BCR signaling required for normal GC selection is uncertain. We have found that protein kinase N1 (PKN1, also known as PRK1) negatively regulates Akt kinase downstream of the BCR and that this regulation is necessary for normal GC development. PKN1 interacted with and inhibited Akt1 kinase and transforming activities. Pkn1
Germinal centers (GCs) are specialized microenvironments in secondary lymphoid organs where high-affinity antibody-producing B cells are selected based on B-cell antigen receptor (BCR) signal strength. BCR signaling required for normal GC selection is uncertain. We have found that protein kinase N1 (PKN1, also known as PRK1) negatively regulates Akt kinase downstream of the BCR and that this regulation is necessary for normal GC development. PKN1 interacted with and inhibited Akt1 kinase and transforming activities. Pkn1
−/− B cells were hyperresponsive and had increased phosphorylated Akt1 levels upon BCR stimulation. In the absence of immunization or infection, Pkn1
−/− mice spontaneously formed
GCs and developed an autoimmune-like disease with age, which was characterized by autoantibody production and glomerulonephritis. More B cells, with fewer somatic BCR gene V region hypermutations were selected in Pkn1 −/− GCs. These results indicate that PKN1 down-regulation of BCR-activated Akt activity is critical for normal GC B-cell survival and selection.
humoral immunity | immunoglobulin | affinity maturation C lass IA phosphotydilinositl-3-OH kinases (PI3Ks) are heterodimeric enzymes composed of a p85α, p85β, or p55γ regulatory subunit and a p110α, p110β, or p110δ catalytic subunit. PI3Ks generate PtdIns(3,4,5)P 3 lipid messengers by phosphorylating PtdIns(4,5)P 2 at the plasma membrane inner leaflet (1) (2) (3) . PtdIns(3,4,5)P 3 interacts with intracellular enzymes that have a pleckstrin-homology (PH) domain (2) . Among PtdIns (3,4,5)P 3 -interacting molecules, Akt, the cell homolog of v-akt, a murine thymoma virus oncogene, is a major class I PI3K downstream effector (4) . The PI3K-Akt pathway has a pivotal role in normal and cancer cell proliferation and survival, by regulating cell cycle and antiapoptotic versus proapoptotic protein expression or activity (5) .
The PI3K-Akt pathway is also important for immune responses (6, 7) . In B cells, PI3K can be activated by the BCR, the CD19-CD21 coreceptor complex, the B-cell PI3K adaptor protein (BCAP), or by cytokine growth factor receptors (8) . Mice deficient in PI3K p85α or p110δ have defects in marginal zone B and B-1 cell development (9) (10) (11) (12) (13) . In contrast, mice with B-cell-specific Akt Phosphatase and tensin homolog deleted from Chromosome 10 (PTEN) phosphatase deficiency have increased PtdIns(3,4,5) P 3 , expanded B cells, and antibody-mediated autoimmune disease (14) . Surprisingly, mature B cells were rescued in B-cell antigen receptor (BCR)-negative mice by ectopically expressing a constitutively active PI3K or specifically ablating B-cell PTEN expression (15) . Moreover, ectopic Akt1 expression in mouse lymphocytes results in peripheral B and T cells (16) , whereas bone marrow chimera mice lacking Akt1 and Akt2 in hematopoietic cells have substantially reduced marginal zone B and B1 cells, similar to PI3K-deficient mice (17) . A human lacking the PI3K p85α subunit had a much earlier block in B-cell development than was evident in p85α-deficient mice (18) . These studies have demonstrated the central importance of the PI3K-Akt pathway in B-cell development and maintenance. After recruitment to the plasma membrane by PtdIns(3,4,5)P 3 , Akt is activated by phosphoinositide-dependent kinase I (PDK1) phosphorylation of Akt serine 473 and by a kinase that phosphorylates Akt threonine 308. PKN 1, 2, and 3, also known as protein kinase C-related kinases (PRKs), may negatively regulate Akt by inhibiting PDK1 activation of Akt (19) (20) (21) (22) (23) (24) . Apoptotic stimulation can also induce PKN1 and PKN2 proteolytic processing and the cleaved C termini may bind and inhibit Akt (19, 25) , whereas PKN3 is required for malignant PI3K effects in prostate cell growth (26) . The studies reported here were undertaken to investigate the role of PKN1 in the PI3K-Akt pathway mediated germinal center B-cell antigen-induced activation, hypermutation, and selection for high avidity antibody production.
To determine whether PKN1 is involved in the PI3K-Akt signaling, we determined the effects of PKN1 in B cells before and after BCR stimulation on Akt activity and generated PKN1-deficient mice to elucidate the physiological roles of PKN1, in vivo. These experiments revealed PKN1 to be indispensable for physiologically appropriate GC B-cell selection through PKN1 affects on BCR-induced Akt activation.
Results
Akt1 and PKN1 Interact in B Cells. Consistent with a role for PKN1 in immune cell survival, growth, or activation, PKN1 mRNA was abundantly expressed in C57BL/6 mouse splenic lymphocytes (SPL), bone marrow (BM), CD4 T cells (CD4), mesenteric lymph node (LYM), peritoneal cavity (PEC), purified spleen B cells (B), and to a lesser extent in thymus (THY) from C57BL/6 mice. Murine embryonic fibroblasts were a nonimmune cell control (Fig.  S1 ). To determine if PKN1 associated with Akt following B-cell receptor activation, Akt1 in Ramos Burkitt lymphoma cells was immune precipitated before and after anti-Ig-mediated (antiIgM) BCR cross-linking. PKN1 coprecipitated with Akt1 from cell lysates stimulated for at least 2 min but not from unstimulated cell lysates (Fig. 1A) . PKN1 and PKN2 C-terminally truncated proteins also precipitated with Akt from cells receiving apoptotic stimuli (19, 25) . Some members of the protein kinase C (PKC) family are also activated by caspase-dependent cleavage after Author contributions: T.Y., G.M., E.K., and H.K. designed research; T.Y., K.S.-Y., T.N., K.M., and S.T. performed research; T.Y., E.K., and H.K. analyzed data; and T.Y., E.K., and H.K. wrote the paper.
The authors declare no conflict of interest. To whom correspondence may be addressed. E-mail: kikutani@ragtime.biken.osaka-u.ac. jp, yasui@ragtime.biken.osaka-u.ac.jp, or ekieff@rics.bwh.harvard.edu. apoptotic stimulation (27) . When B cells were stimulated with anti-IgM antibody for >12 h, PKN1 and PKCδ proteolytically processed forms were detected (Fig. 1B) . Full-length PKN1 coprecipitated with Akt1 (Fig. 1A) . No interaction was detected between processed PKN1 and Akt1, even after longer stimulation.
PKN1 Inhibits Akt1 Kinase and Transforming Activities. When fulllength PKN1 (PKN1FL), kinase dead (PKN1KD), or constitutively active PKN1 (PKN1CA) lacking the N-terminal regulatory region were coexpressed with Akt1 in 293T cells, PKN1FL, PKN1CA, and PKN1KD coprecipitated Akt1 with efficiencies that correlated with PKN1FL, -CA, or -KD expression ( Fig. 2A) . Furthermore, PKN1FL expression inhibited myristoylated, highly plasma membrane associated, and constitutively activated Akt1 (MyrAkt), and PKN1CA, which was slightly more efficiently expressed, further inhibited MyrAkt activity (Fig. 2B) . HAMyrAkt expressed in 293T cells, HA-immune precipitated and assayed for Akt/Serum and glucocorticoid-inducible kinase (SGK) substrate peptide phosphorylation, in vitro, resulted in vector control transfected cells with 20,000 cpm SGK signal (Fig.  2B) . HA-MyrAkt increased SGK to ∼55,000 cpm, 35,000 cpm above vector control, and wtPKN1FL reduced cotransfected HA-MyrAkt activity to ∼40,000 cpm (15,000 cpm less than HAMyrAkt), without substantially decreasing HA-MyrAkt by Western blot (Fig. 2B) . Moreover, similarly expressed, catalytically active, PKN1CA, reduced HA-MyrAkt activity to 28,000 cpm, only 8,000 cpm above vector control. These experiments done in triplicate and repeated three times, with narrow error bars and Student's t test, P < 0.01, indicate that PKN1 significantly negatively regulates Akt.
To assess the impact of PKN1 on Akt-mediated cell effects, 3Y1 rat fibroblast cells were retrovirally cotransduced with MyrAkt and PKN1CA and cultured in soft agar. Colonies appeared 21 d after MyrAkt retroviral transduction, but not after control vector (Fig. 2C ). Coexpressing PKN1CA with MyrAkt significantly reduced colony number and size, whereas kinaseinactive PKN1, (PKN1KD), failed to inhibit MyrAkt-induced transformation, even though PKN1KD associated with Akt1 (Fig. 2C) . Moreover, FoxO4a phosphorylation, a downstream target of Akt, was suppressed in cells cotransfected with PKN1CA, but not PKN1KD (Fig. 2D) (28) . These data indicate that PKN1 is an Akt inhibitor.
PKN1 Deficiency Results in Spontaneous GC Formation and Autoantibody
Production. To clarify the physiologic PKN1 role, in vivo, PKN1-deficient (Pkn1 −/− ) mice were made (Fig. S2 ). Pkn1 −/− mice were born in a Mendelian ratio and appeared normal. Defects in lymphocyte development, as assessed by differentiation antigen expression were not detected in Pkn1 −/− mice <12 wk of age. However, spontaneous splenic GC formation was evident in comparative studies of Pkn1 −/− and normal mouse spleens more than 30 wk of age, even in the absence of immunization or infection (Fig. 3A) . CD95
+ peanut agglutinin (PNA) + and GL7 + PNA + GC B cells were also increased in Pkn1 −/− mice by flow cytometric analyses ( Fig. 3 B and C) . Furthermore, Pkn1
−/− mice also had significantly increased spleen cell numbers ( Fig. 3D ) and substantially elevated serum Ig levels (Fig. 3E) . Moreover, aged Pkn1 −/− mice had elevated antidouble-stranded (ds) DNA antibody serum levels (Fig. 3F) . Glomeruli from some Pkn1 −/− kidneys also had increased mesangial cell numbers and thickened basement membranes, characteristic of proliferative glomerulonephritis (Fig. 3G, Top) . In addition, IgG and complement component C3 deposition was evident in mesangial regions of Pkn1 −/− mice and not in control mice of the same age (Fig. 3G , Middle and Bottom). or IL-4 alone (Fig. 4A) . Furthermore, PKN1-deficient B-cell hyperresponsiveness to anti-IgM antibody only or anti-IgM plus anti-CD40 antibody was confirmed using an in vitro 5-bromo-2′-deoxy-uridine (BrdU) incorporation assay and IL-6 production ELISAs (Fig. 4 B and C) . Whereas B lymphocytes normally undergo activation-induced cell death (AICD) after BCR crosslinking with immobilized anti-IgM antibodies, PKN1-deficient B cells were resistant to AICD when stimulated by anti-IgM antibody coated plates (Fig. 4D ). These findings indicate that PKN1 deficiency affects BCR signaling required for cell survival, but not the threshold required for BCR activation. When purified splenic CD4 + T cells were stimulated with anti-CD3 and anti-CD28 antibody or by phorbol ester and a calcium ionophore, WT and Pkn1 −/− cell proliferative responses were not different, indicating that PKN1 is dispensable for T-cell activation induced by T-cellantigen receptor ligation (Fig. S3) .
We next investigated the basis for PKN1-deficiency effects on BCR signaling. As expected, Akt1 phosphorylation patterns differed between Pkn1 −/− B cells and WT B cells. Pkn1 −/− B cells consistently had enhanced "basal" Akt1 S473 phosphorylation before BCR engagement, although Akt1 phosphorylation was similarly robustly induced within 5 min and maintained for 60 min after BCR stimulation in both WT and Pkn1 −/− B cells (Fig.   4E ). However, Pkn1 −/− B cells consistently had higher late phase Akt S473 phosphorylation from 4 to 24 h after BCR stimulation (Fig. 4F) . Despite dramatic effects on Akt1 regulation, WT and Pkn1 −/− B cells were not significantly different in phosphorylation of other signaling molecules downstream of BCR, including IKKα/β, Erk, JNK, and p38 ( Fig. S4 A and B) , indicating that PKN1 deficiency specifically affects Akt activation, among various downstream BCR signaling molecules. Indeed, Bcl-xL induction, a GC B-cell-specific antiapoptotic effect of PI3K-Akt signaling (12, 29) , was enhanced in PKN1-deficient B cells stimulated by anti-IgM antibody (Fig. 4G) . Moreover, FoxO1, which is directly degraded after Akt-mediated phosphorylation (28, 30, 31) , was down-regulated more robustly in PKN1-deficient B cells than WT B cells (Fig. 4H) .
Humoral Immune Responses in Pkn1
−/− Mice. To evaluate the impact of the PKN1 deficiency on humoral immune responses, young Pkn1 −/− mice that had not formed GCs were immunized with 4-hydroxyl-3-nitrophenyl-acetyl (NP)-conjugated chicken γ-globulin (CGG). Pkn1 −/− mice developed much larger GCs than WT mice after immunization. GC B-cell numbers were several-fold higher in Pkn1 −/− mice than WT mice ( Fig. 5 A and  B) . Most GC B cells in Pkn1 −/− mice weakly expressed surface IgG, whereas surface Ig expression was down-regulated in most GC B cells in WT mice (Fig. S5) . However, serum levels of NP-specific antibodies were not significantly different between Pkn1 −/− and WT mice (Fig. S6) , indicating that antigen-specific serum antibody titers do not reflect GC B-cell numbers in PKN1-deficient animals.
Abnormal GC Formation Is Intrinsic to Pkn1
−/− B Cells. To determine whether aberrant GC reactions observed in Pkn1 −/− mice were intrinsic to B cells, equal numbers of naïve Pkn1 −/− B cells and GFP-expressing Pkn1 +/+ B cells were transferred into B celldeficient (μMT) mice that selectively lack mature B cells. Both groups of mice were immunized with keyhole limpet hemocyanin (KLH) (32) . Three weeks after immunization, Pkn1 −/− B cells significantly outcompeted Pkn1 +/+ B cells in the spleen and mesenteric lymph nodes, although Pkn1 −/− and Pkn1 +/+ B cells had comparable ability to home to lymphoid tissues in μMT mice 7 d after transfer (Fig. 5C) . Specifically, most GL-7
+ GC B cells after transfer were Pkn1 −/− in origin (96.3% in the spleen and 82.7% in the mesenteric lymph nodes), strong evidence that accelerated GC reactions in Pkn1 −/− mice were due to intrinsic B-cell hyperactivation (Fig. 5D ).
Ig Locus of Pkn1
−/− GC B Cells Undergoes Reduced Somatic
Hypermutation. The proceeding observations indicate that PKN1 deficiency results in B-cell-antigen hyperresponsiveness and aberrant GC formation. To evaluate GC quality, antigenspecific GC B cells from Pkn1 −/− mice immunized with NP-CGG/alum were compared with the frequency of NP-binding +
GC B cells was significantly lower in Pkn1
−/− mice than WT mice after immunization (Fig. 6 A and B) , suggesting that antigenspecific B-cell selection is impaired in the GCs of Pkn1 −/− mice, even though GC formation is significantly enhanced. Sorting of single NP-binding + B cells from immunized mice and sequencing the Ig heavy chain V H 186.2-DFL16.1 gene, which is preferentially used in NP-specific B cells in C57BL/6 mice revealed no differences in the frequencies of NP-specific GC B cells with V H 186.2 between Pkn1 −/− and WT mice (Table S1 ). However, the frequency of B cells expressing the V H 186.2 gene with more than four mutations was significantly lower in Pkn1 −/− mice than in control mice (59% vs. 23%) (Fig. 6C) , although there were no differences in V H 186.2-DFL16.1 use between the two groups (93% vs. 80%) (Table S1 ). Pkn1 −/− mice also had a lower frequency of B cells carrying the tryptophan (W) to leucine (L) mutation at position 33 of the V H 186.2 gene, a signature of a high affinity for NP hapten. In addition, the ratio of replacement to silent mutations (R/S) in the entire complementarity-determining region (CDR) of the Ig heavy chain gene was also decreased in Pkn1 −/− mice (Table S1 ). However, Pkn1 −/− mice did not have decreased serum titers for high-affinity antibodies, which were detected using a low-valency antigen (Fig. S6 ). This result is likely due to the serological method and may not have sufficient sensitivity to detect a 50% reduction in antibodies with W to L mutation at position 33, consistent with the hypothesis that PKN1 is critical for negative selection of B cells that produce less mutated, low-affinity antibodies. Discussion PKN1 Negatively Regulates Signals Downstream of the BCR. PKN1 and PKN2 have been previously suggested to indirectly or directly negatively regulate Akt kinase activity (19, 20) . The present study has confirmed these previous findings and found that PKN1 down-regulates Akt transforming activity, which is a major Akt biological activity. Moreover, analysis of Pkn1 −/− mice also revealed that PKN1 inhibition of Akt is critical for regulated B-cell activation and survival, particularly in GCs. The inhibitory pathway appears to be regulated by BCR signals, such as PI3K-mediated activation, because PKN1 physically interacted with Akt in B cells within a few minutes after BCR stimulation. Apoptotic stimuli have been shown to induce PKN2 proteolytic processing and the processed C-terminal region but not full-length PKN2 directly binds to and inhibits Akt (19) . Unlike apoptotic stimuli, BCR stimulation induced an interaction between Akt1 and full-length PKN1, but not the processed form, although PKN1 processing was observed 12 h after stimulation. PKN1 and PKN2 can inhibit PDK1, an important Akt activator (20, (22) (23) (24) . However, we failed to detect interaction between PDK1 and Akt1 or PKN1 before or after BCR stimulation. Instead, our findings are more compatible with PKN1-mediated inhibition of Akt1 being regulated by BCR signals, although the detailed mechanism remains to be determined. GC formation can be attributed to enhanced Akt activity in B cells that is caused by the PKN1 deficiency.
PKN1-Mediated Regulation of Akt Activity Is Necessary for B-Cell
Maintenance of GC Quality. Although the proportion of NPbinding + GC B cells was lower in Pkn1 −/− mice than in WT mice, the total number of antigen-specific GC B cells may be comparable between the two groups when the larger sizes of GCs in Pkn1 −/− mice are taken into consideration. Consistent with this, there were no detectable differences in the serum titers of antigen-specific antibodies. Thus, it appears that the enlarged GCs of Pkn1 −/− mice are due to abnormally selected B cells that express low-affinity antibodies. Indeed, the proportion of B cells carrying fewer mutations in the V H 186.2 gene was higher in NP-binding + GC B cells from Pkn1 −/− mice than those of WT controls. These abnormally selected B cells probably contain self-reactive clones because aged Pkn1 −/− mice had high serum levels of autoantibodies.
BCR signals are transduced through multiple pathways, including PLCγ and PI3K-Akt pathways (36) . However, it was unclear which BCR signaling pathway is critical for affinity maturation and GC B-cell selection. Our findings substantiate the importance of the PI3K-Akt pathway in GC B-cell survival and selection. Furthermore, we clearly demonstrate that PKN1-mediated Akt control has a critical role in quality control of GC B cells by establishing a selection threshold based on BCR signal strength. The present study therefore provides unique insight into control mechanisms of GC B-cell selection and the escape mechanisms of self-reactive B cells.
Materials and Methods

Pkn1
−/− mice were generated by disrupting the gene within E14 (129) embryonic stem cells using standard procedures and then backcrossing these mice to C57BL/6 mice. Mice were maintained in pathogen-free animal facilities at the Research Institute for Microbial Diseases, Osaka University and immunized intraperitoneally with 100 μg NP-CGG (Biosearch Technologies) in alum under the guidelines of Osaka University for animal studies; this study was approved by the institutional animal care and use committee (permission number: H21-28-0). Western blotting, immunoprecipitation, ELISA, and the in vitro kinase assay were performed following standard or published protocols. For colony transforming assay, Rat Akt1 and PKN1 cDNA were cloned into murine stem cell virus-based retroviral vectors and retrovirally transduced into 3Y1 rat fibroblast cells. Cell growth in soft agar was examined as previously described. For DNA sequence analysis of Ig genes, total RNA was isolated from single NP-binding + B cells that were sorted using a flow cytometer and then cDNA was synthesized. Nested PCR for the V H 186.2-DFL16.1 gene was performed, followed by DNA sequencing. For more details, see SI Materials and Methods.
